Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026
Biofrontera Inc., a U.S.-based biopharmaceutical company specializing in photodynamic therapy for dermatological conditions, announced it will release its Q1 2026 financial results on May 14, 2026. The company will also hold a conference call to discuss the results and provide a business update.